Dr. Jeremiah Deneve 

Associate Professor of Surgery
University of North Carolina
NC 27599
View Contact Information

Schedule a Conversation with a HIPEC Surgeon

The surgeon or staff member will make their best effort to call you at your requested time. If they become unavailable you will receive a text.

Fill out my online form.

Board Certified

Board certification by an ABMS Member Board is the premier, independently assessed credential attainable in medicine today.

Dr. Jeremiah Deneve is affiliated with University of North Carolina

Fellowship Experience

Moffitt Cancer Center

Additional Information

Jeremiah L. Deneve, DO, FACS is a surgical oncologist recognized as an expert in the multidisciplinary management of patients with peritoneal malignancies, hyperthermic intraperitoneal chemotherapy (HIPEC), pancreatic, hepatobiliary, gastric, colon malignancies as well as soft tissue sarcoma and melanoma.

Titles & Roles
• Associate Professor of Surgery, UNC, Department of Surgery
• Surgical Oncologist, UNC and Lineberger Comprehensive Cancer Center
• Society of Surgical Oncology Colorectal Disease Site Working Group
• Association of Academic Surgeons Class Councilor 2012
• UNC CGSO Fellowship Program Director
• Fellow American College of Surgeons

Areas of Expertise
• Peritoneal Malignancies
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Gastric Cancer
• Colorectal Cancer
• Gastrointestinal Stromal Tumors
• Soft Tissue Sarcoma
• Melanoma
• Isolated Limb Infusion (ILI)

Biography
Dr. Deneve is board certified by the American Board of Surgery in general surgery and surgical oncology fellowship trained with clinical and research interest in the treatment and management of peritoneal malignancies. He also has interest in treating gastric, pancreatic, hepatobiliary and colorectal malignancies as well as soft tissue sarcoma and melanoma. He began academic surgical oncology practice at the University of Tennessee Health Science Center (Memphis, TN) where he practiced from 2012-2022. He joined faculty at the University of North Carolina (Chapel Hill, NC) in 2023 where he focuses his clinical efforts on peritoneal surface malignancies and melanoma. He has several roles in teaching and training of medical students and surgical residents and is the Program Director for the Complex General Surgical Oncology Fellowship.

Dr. Deneve is a member of the American College of Surgeons, the Society of Surgical Oncology, the Association for Academic Surgery, the Society of University Surgeons, Southeastern Surgical Congress and the North Carolina Chapter of the American College of Surgeons. He participates in clinical trial enrollment at Lineberger Comprehensive Cancer Center and with the Southwest Oncology Group and has an interest in clinical research and outcomes. Dr. Deneve has published on a variety of malignancy related topics and his research has been presented at several national meetings and published in peer-review journals.

Education & Training
Dr. Deneve graduated Magna Cumme Laude from Auburn University at Montgomery, AL with a B.S. in Biology. He completed medical school at the Chicago College of Osteopathic Medicine (Midwestern University) in Downers Grove, IL. He completed surgical training at Emory University in Atlanta, GA. During his surgery residency training, he completed a post-doctoral research fellowship with the Carlyle Fraser Research Laboratory and was awarded a National Institute of Health (NIH) research grant on the role of tissue factor in the inflammatory response to cardiopulmonary bypass. Following completion of general surgery training, Dr. Deneve completed a surgical oncology fellowship at Moffitt Cancer Center in Tampa, FL.